KATHY ROBB: Open Payments
NPI 1639347248 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,112 in 276 payments from 42 companies in 2025. Trend: 2023 $4,326 · 2024 $5,165 · 2025 $6,112
Food & beverage: $6,037Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $683 |
| AstraZeneca Pharmaceuticals LP | 23 | $629 |
| SOBI, INC | 16 | $406 |
| Daiichi Sankyo Inc. | 25 | $392 |
| GlaxoSmithKline, LLC. | 17 | $367 |
| Astellas Pharma US Inc | 22 | $329 |
| Eisai Inc. | 10 | $248 |
| Exelixis Inc. | 11 | $234 |
| Stemline Therapeutics Inc. | 6 | $234 |
| Merck Sharp & Dohme LLC | 10 | $220 |
Products named: RYBREVANT, Enhertu, CALQUENCE, OJJAARA, Lenvima, CABOMETYX, Vonjo, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
